Filter
48
Filtered Results: 48
Text search:
nanoparticles
Featured
Recommendations
9
New Publications
5
Language
Document type
Studies & Reports
16
Guidelines
14
No document type
10
Manuals
4
Fact sheets
4
Countries / Regions
Syria
3
Middle East and North Africa
3
Russia
3
Yemen
3
Global
2
Ukraine
1
Latin America and the Carribbean
1
Sudan
1
South Sudan
1
Authors & Publishers
Publication Years
Category
Countries
7
Clinical Guidelines
3
Pharmacy & Technologies
2
Capacity Building
1
Women & Child Health
1
Toolboxes
COVID-19
22
Ebola & Marburg
6
Planetary Health
6
Pharmacy
3
NTDs
3
Global Health Education
3
Rapid Response
2
AMR
2
HIV
1
TB
1
Health Financing Toolbox
1
Conflict
1
Zika
1
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
This report summarizes the latest scientific knowledge on the links between exposure to air pollution and adverse health effects in children. It is intended to inform and motivate individual and collective action by health care professionals to prevent damage to children’s health from exposure to ...
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Pharmaceuticals 2024, 17(6), 691; https://doi.org/10.3390/ph17060691
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
This booklet presents key messages for action, summarized from a set of
chapters on different environmental health issues.
orientaciones provisionales, 23 de diciembre de 2020
En este documento se resumen las recomendaciones de la OMS para utilizar de forma racional los equipos de protección personal (EPP) tanto en los centros sanitarioscomo en los domicilios, así como durante la manipulación...
23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health...
Временное руководство23 декабря 2020 г.
23 décembre 2020 Ce document résume les recommandations de l'OMS concernant l'utilisation rationnelle des équipements de protection individuelle (EPI) dans les établissements de soins de santé et les stratégies temporaires en cas de pénurie aiguë d'approvisionnement. Ce document contient ég...
interim Guidance 1 December 2020. Updated version
This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prevention and control professionals, health care manag...
Применение масок в условиях COVID-19
recommended
Временные руководящие принципы 1 декабря 2020 года. Обновленная версия
В этом документе представлено обновленное руководство по использованию масок в медицинских ...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
